Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Siloam Biosciences Inc
Profile last edited on: 6/26/19      CAGE: 335T6      UEI:

Business Identifier: Immunological diagnosis: biomedical point-of-care testing diagnostics,
Year Founded
2004
First Award
2004
Latest Award
2012
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation

Location Information

413 Northland Boulevard
Cincinnati, OH 45240
   (513) 429-2976
   N/A
   www.siloambio.com
Location: Single
Congr. District: 01
County: Hamilton

Public Profile

In May 2018 it was announced that MiCo BioMed, a KONEX-listed (Korean) company would acquire Siloam Biosciences, Inc.. MiCo BioMed, -- established in 2009 as NanoBioSys -- has developed molecular diagnostic products for virus infection by extracting genes and detecting bacteria in them and now manufactures and sells molecular diagnostic products and biochemical diagnostic products. The SBIR firm acquired - Siloam Biosciences - is a medical device company that had developed the first ever open source Point-of-Care Test platform: diagnostic kits and equipment based on a biomedical microelectromechanical systems (Bio MEMS) platform. Siloam's TROVA™ POCT platform allows for ultra-high sensitivity and wide dynamic range assays to be developed very quickly. The TROVA™ platform - driven by Siloam’s Optimiser™ technology platform - integrates the power of microfluidics in an easy-to-use pla

Extent of SBIR involvement

User Avatar
Phase I Awards
7
Phase II Awards
2
Conversion Rate
28.57%
Phase I Dollars
$785,120
Phase II Dollars
$1,404,389
Total Awarded
$2,189,509

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
---
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2012 1 NIH $198,570
Project Title: IGF::OT::IGF Other Functions Siloam Phase I, Topic 309, Low Volume, Ultra-Sensitive Immunodiagnostic System
2010 1 NIH $150,000
Project Title: Tas::75 0893::Tas Rapid Quantitative Point Of Care Test For Nicotine Metabolite
2009 2 NIH $770,963
Project Title: High-Throughput Plastic Microfabrication Technologies for Smart Lab-on-a-Chips
2006 1 NSF $97,196
Project Title: Rapid Toxic Alcohols Detection Using On-Chip Biosensor Array for Emergency Care
2005 2 Army $798,140
Project Title: A Handheld Monitoring System For Biomarkers Of Response From Blood

Key People / Management

  Chong H Ahn -- President

  Jungyoup Jay Han -- Vice President of Product Development

  Junhai Kai

  Jae Y Lee

  Aniruddha P Puntambekar

Company News

May 25 2018
MiCo BioMed to acquire Siloam Biosciences